Tucha, O. and Naumann, M. and Berg, D. and Alders, G. L. and Lange, Klaus W. (2001) Quality of life in patients with blepharospasm. ACTA NEUROLOGICA SCANDINAVICA, 103 (1). pp. 49-52. ISSN 0001-6314
Full text not available from this repository. (Request a copy)Abstract
Objectives - Administration of botulinum neurotoxin A (BONT/A) is a common and effective treatment of blepharospasm. There is, however, no information regarding the emotional and social well-being of patients with blepharospasm and patient acceptance of BONT/A therapy. The purpose of this study was to investigate aspects of quality of life of patients with blepharospasm and level of patient satisfaction with treatment. Material and methods - Fifty-one patients with blepharospasm who had been treated with BONT/A for years completed a questionnaire providing information about quality of life. Results Results revealed reductions in social and emotional well-being of patients but, nonetheless, good acceptance of BONT/A therapy. The positive effects of BONT/A therapy were, however, accompanied by fear of a decreasing effect of BONT/A injections. Conclusion - Although the objective findings following BONT/A injections in the treatment of blepharospasm are appreciated by the patients, their well-being is affected by fears and depression.
| Item Type: | Article |
|---|---|
| Uncontrolled Keywords: | BENIGN ESSENTIAL BLEPHAROSPASM; BOTULINUM-A TOXIN; OF-LIFE; HEMIFACIAL SPASM; QUESTIONNAIRE; RADIOTHERAPY; GLIOMAS; blepharospasm; quality of life; social well-being; emotional well-being; botulinum toxin |
| Subjects: | 100 Philosophy & psychology > 150 Psychology |
| Divisions: | Human Sciences > Institut für Psychologie > Lehrstuhl für Psychologie III (Biologische, Klinische und Rehabilitationspsychologie) - Prof. Dr. Klaus W. Lange |
| Depositing User: | Dr. Gernot Deinzer |
| Date Deposited: | 22 Feb 2022 08:08 |
| Last Modified: | 22 Feb 2022 08:08 |
| URI: | https://pred.uni-regensburg.de/id/eprint/41814 |
Actions (login required)
 |
View Item |
